Daratumumab with Pomalidomide and Dexamethasone at First Relapse in Relapsed and/or Refractory Multiple Myeloma (RRMM) Patients
Year: 2021
Type: conference-abstract
Source: Blood
Institutions: Emory University, Winship Cancer Institute, Emory Healthcare
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3213124528
